This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schmid C, Labopin M, Nagler A, Bornhäuser M, Finke J, Fassas A et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 2007; 25: 4938–4945.
Dong L, Gao ZY, Yu XJ, Tan XY, Lui JH, Lu F et al. HLA disparity is associated with improved outcomes in hematological malignancies after family HLA-mismatched / haploidentical HCT but not URD. ASH Annu Meet Abstr 2012; 120: 2014.
Kanda Y, Chiba S, Hirai H, Sakamaki H, Iseki T, Kodera Y et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991–2000). Blood 2003; 102: 1541–1547.
Tischer J, Engel N, Fritsch S, Prevalsek D, Hubmann M, Schulz C et al. Second haematopoietic SCT using HLA-haploidentical donors in patients with relapse of acute leukaemia after a first allogeneic transplantation. Bone Marrow Transplant 2014; 49: 895–901.
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641–650.
Cieri N, Greco R, Morelli M, Giglio F, Assanelli A, Forcina A et al. Post-transplant cyclophosphamide haplo-HSCT revised: peripheral blood stem cell graft and sirolimus to enhance immune reconstitution and graft versus leukemia effect in patients with active leukemia. ASH Annu Meet Abstr 2013; 122: 2118.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
Solomon SR, Sizemore CA, Sanacore M, Zhang X, Brown S, Holland HK et al. Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who Lack conventional donors is well tolerated and produces excellent relapse-free Survival: results of a prospective phase II trial. Biol Blood Marrow Transplant 2012; 18: 1859–1866.
Acknowledgements
We are grateful to all of the nursing staff at the 5H BMT unit of CMUH for their excellent care of our transplant patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
This work was supported in part by research grants from the Taiwan National Science Council (NSC-101-2321-B-039-005 to S-PY) and the China Medical University Hospital (DMR-99-010 to S-PY). The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yeh, SP., Lin, CC., Lin, CH. et al. Second haploidentical peripheral blood stem cell transplantation for treatment of acute leukemia with relapse after first allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 50, 1001–1003 (2015). https://doi.org/10.1038/bmt.2015.67
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.67
This article is cited by
-
Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2021)
-
Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation
Annals of Hematology (2020)